Factual data · GO/NO-GO verdict · Financial model calibrated over 96 months
Taking over or creating a pharmacy in Amsterdam requires a Doctor of Pharmacy degree, geographic quota compliance (1 per 2,500-3,500 inhabitants), and substantial investment (1.2M €-5.1M € €, mostly business acquisition).
Dominant profile: business · touristique · capitale
Amsterdam (North Holland, Netherlands) has about 873K inhabitants and shows dense business fabric (HQs, B2B services, professionals), and strong tourist footfall boosting seasonal spending and average ticket. For a pharmacy project, this means a high average ticket and a setup cost above national by 45 %.
Local purchasing power and lead density allow targeting the high end of the revenue range from year 2. Concretely, initial investment calibrated for Amsterdam ranges from 1.2M € to 5.1M €, and Year 1 target revenue sits between 2M € and 6.1M € — a range that already factors in the local coefficients of this city (+45% vs average on costs, +35% vs average on purchasing power).
Competitive density: high (dense supply, segmentation required).
Dominant players: regulated public-insurance sector, few private chains.
Positioning recommendation: Competitive positioning required: sector margin is tight, edge comes from operational efficiency.
| Indicator | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Year 1 revenue | 2M € → 6.1M € | ×1,18 (ramp-up) | ×1,32 (steady-state) |
| Target net margin | negative to low | 4 % | 10 % |
| Working capital (days of revenue) | 45-60 d | 35-50 d | 30-45 d |
| Cumulative ROI | investment | ~50 % | Payback at 96 months |
These ratios are calibrated on MarketLens sector benchmarks and adjusted by local coefficients of Amsterdam, Netherlands (cost +45% vs average, income +35% vs average).
This page combines multiple data sources for a factual analysis calibrated on Amsterdam.
MarketLens combines AI market study, business plan calibrated for 24 countries, and post-launch monitoring. Everything exportable to PDF, PowerPoint, Excel and Word.